OS Therapies (OSTX)
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteo...
- Open
- 1.840
- High
- 1.960
- Low
- 1.840
- Prev. Close
- 1.820
- Volume
- 982.58K
- Turnover
- 1.88M
- Avg Price
- 1.910
- Bid/Ask Ratio
- --
- Amplitude
- 6.59%
- 52wk High
- 2.350
- Volume Ratio
- 3.63
- Turnover Ratio
- 2.60%
OS Therapies Analyst Rating
View moreForecast & Rating
Sep 4, 2026Price forecast
$8.50352.13%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Sep 2 at 11:21 AM
OS Therapies management to attend H.C. Wainwright Global Investment Conference
- StockTitan · Sep 2 at 03:20 AM
OS Therapies Provides OST-HER2 Metastatic Osteosarcoma Program Update and Announces Upcoming Conference Attendance | OSTX Stock News
- Tip Ranks · Aug 24 at 07:05 AM
Jason McCarthy Initiates Buy on OS Therapies, Citing Advancing OST-HER2 Program, Key Regulatory Catalysts, and Strengthened Cash Runway Into 2027
- TradingView · Aug 21 at 08:53 PM
OS Therapies Launches $75 Million ATM Program Under Sales Agreement With Jefferies
- PUBT · Aug 21 at 08:51 PM
OS Therapies launches USD 75 million at-the-market equity offering via Jefferies
